Another tangential benefit of Covid mRNA vaccination, albeit not applicable to everyone, obviously.

 

Quote

For their study, the researchers used institutional databases to retrospectively examine survival outcomes by mRNA COVID vaccination status in cancer patients undergoing immunotherapy. The study included individuals with available biopsies from August 2019 to August 2023.

 

https://www.medpagetoday.com/meetingcoverage/esmo/118051

 

Quote

Preclinical work from the research team demonstrated how mRNA vaccination can induce a surge in type I interferon-dependent immunity -- priming T cells to infiltrate tumors -- and analysis of tumor expression profiles found vaccination to be associated with increased levels of PD-L1, a prime target of blockbuster immunotherapy drugs.

 

Yippee!

From the link:

Preclinical work from the research team demonstrated how mRNA vaccination can induce a surge in type I interferon-dependent immunity -- priming T cells to infiltrate tumors 

 

-----------------------------------------------------------------------------

 

It's because mRNA technology was being developed for decades, not for Covid, but for other illnesses such as cancer. It was specifically being developed to treat cancer and other illnesses.

 

So this finding would be consistent with that. 

 

A fuller version of the OP's post:

Cancer Study Links COVID Shots to Longer Survival

— 3-year survival twice as high with mRNA vaccine in lung cancer patients receiving immunotherapy

October 20, 2025

 

"BERLIN -- Non-small cell lung cancer (NSCLC) patients starting immunotherapy were nearly twice as likely to be alive 3 years later if they got a COVID-19 vaccine around the time of treatment, a researcher reported here.

 

Retrospective data in advanced NSCLC found that mRNA COVID vaccination within 100 days of initiating a checkpoint inhibitor was associated with higher 3-year survival rates compared with no vaccination (55.8% vs 30.6%; adjusted HR 0.51, 95% CI 0.37-0.71, P<0.0001), according to Adam Grippin, MD, PhD, of the University of Texas MD Anderson Cancer Center in Houston.

 

Analyses in metastatic melanoma mirrored the results, with 3-year survival rates of 67.5% and 44.1%, respectively (adjusted HR 0.34, 95% CI 0.17-0.69, P=0.0029), findings presented at the European Society for Medical Oncology (ESMO) showed.

...

"The really exciting part of our work is that it points to the possibility that widely available, low-cost vaccines have the potential to dramatically improve the effectiveness of certain immune therapies," Grippin said in a press release. "We are hopeful that mRNA vaccines could not only improve outcomes for patients being treated with immunotherapies but also bring the benefits of these therapies to patients with treatment-resistant disease."

 

(more)

 

MedPage Today

https://archive.ph/GsTF7

 

 

The Covid-19 pandemic traumatized people and societies, but it also spurred medical advances in a very big way. 

 

Now the technology is coming into its own in other areas, like as a possible treatment for another killer: pancreatic cancer. We talk about this with Derrick Williams from DW science and ask him: How likely is it that mRNA will lead to a successful cancer treatment? And what obstacles are still left to overcome?

 

 

 

It's good that some promising research into cancer treatments is still going on in the U.S., despite the following:

 

Trump Is Shutting Down the War On Cancer

America’s cancer research system, which has helped save millions of lives, is under threat in one of its most productive moments.

 

Sept. 14, 2025

...

"When America declared war on cancer more than 50 years ago, there was a misguided assumption outside the scientific community that it would be only a matter of years before the disease was eradicated — that defeating cancer would be no different than building an atomic bomb or putting a man on the moon. But there would be no miracle cure: As of this writing, some 40 percent of Americans will be diagnosed with cancer at some point in their life.

 

What there would be, however, was decades of minor breakthroughs that would accrue over time, transforming both our understanding of the disease and our ability to treat it. One way to measure the cumulative effect of those breakthroughs is with statistics: In the mid-1970s, America’s five-year cancer-survival rate sat at 49 percent; today, it is 68 percent. You can also correlate America’s sustained investment in cancer research directly with these returns: According to a recent study in The Journal of Clinical Oncology, every $326 that our government spends researching cancer extends a human life by one year. Now an extraordinarily successful scientific research system — one that took decades to build, has saved millions of lives and generated billions of dollars in profits for American companies and investors — is being dismantled before our eyes. [emphasis added]

 

In a matter of months, the Trump administration has canceled hundreds of millions of dollars in cancer-related research grants and contracts, arguing that they were part of politically driven D.E.I. initiatives, and suspended or delayed payments for hundreds of millions more. It is trying to sharply reduce the percentage of expenses that the government will cover for federally funded cancer-research labs. It has terminated hundreds of government employees who helped lead the country’s cancer-research system and ensured that new discoveries reached clinicians, cancer patients and the American public. And the president’s proposed budget for the next fiscal year calls for a more-than-37-percent cut to the National Cancer Institute — the N.I.H. agency that leads most of the nation’s cancer research — reducing it to $4.5 billion from $7.2 billion. Adjusting for inflation, you have to go back more than 30 years to find a comparably sized federal cancer-research budget."

 

(more)

 

New York Times

https://archive.ph/H6403

 

Wait till  Red and his sidekick come along.

Not to mention the loss, at least in the U.S., of the following that also had serious cancer fighting prospects:

mRNA technology could hold hope for fighting cancer, but future is in doubt under RFK Jr.

August 13, 2025

 

"If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again. 

 

These types of vaccines use messenger RNA, or mRNA, to prompt the body to make proteins that induce an antibody response to protect against a pathogen. The science behind it is also being studied for a wide range of other uses, from fighting cancer to treating autoimmune conditions and more. 

 

Health experts have criticized the move to defund this research, pointing to the impact it will have on America's ability to develop breakthroughs against deadly or debilitating diseases.  Jeff Coller, professor of RNA biology and therapeutics at Johns Hopkins University, called the cuts a "completely reckless decision from Robert F. Kennedy Jr." that was "clearly being made for political motivations and not those that are rested in our science."

...

mRNA studied for pancreatic cancer, rare diseases and more

Collier said one of the most exciting avenues for mRNA technology is in the treatment of deadly cancers, including pancreatic cancer, which is fatal for many patients within six months to a year.  In recent years, researchers have been testing the effectiveness of using an mRNA vaccine to target the cancer. A small NIH-funded clinical trial by Sloan Kettering in 2023 used infusions of an mRNA vaccine to help boost T cells in the immune system of pancreatic cancer patients. The results, published in the journal Nature, showed improvements among about 50% of participants. [emphasis added]

 

(more)

 

https://www.cbsnews.com/news/mrna-vaccine-defunding-cancer-treatment-rfk-jr/

 

 

 

8 minutes ago, still kicking said:

Wait till  Red and his sidekick come along.

I had to laugh but very true. 

52 minutes ago, save the frogs said:

The Covid-19 pandemic traumatized people and societies, but it also spurred medical advances in a very big way. 

 

Now the technology is coming into its own in other areas, like as a possible treatment for another killer: pancreatic cancer. We talk about this with Derrick Williams from DW science and ask him: How likely is it that mRNA will lead to a successful cancer treatment? And what obstacles are still left to overcome?

 

 

Scientists in Russia have developed an mRNA-based cancer vaccine, which has reportedly shown 100 per cent efficacy during clinical trials. The vaccine, called Enteromix, now reportedly awaits final approval from the Ministry of Health before being available to the public

 

https://www.firstpost.com/explainers/russia-cancer-vaccine-enteromix-13931800.html

 

The vaccine will apparently be used to treat cancer patients, rather than given to the general public to prevent cancer—and it will be personalized to each patient.

 

https://www.newsweek.com/russia-launch-free-cancer-vaccine-2025-2001432

 

Russia has announced that its experimental mRNA-based cancer vaccine, Enteromix, showed 100 per cent efficacy and safety in preclinical trials conducted on animals. The vaccine, designed to target cancers such as colorectal cancer, glioblastoma, and melanoma, can prevent tumour development and promote tumour regression.

 

https://www.timesnownews.com/health/russia-says-its-enteromix-cancer-vaccine-has-achieved-100-success-rate-in-trials-article-152701442

 

 

52 minutes ago, NoDisplayName said:

Russia has announced that its experimental mRNA-based cancer vaccine, Enteromix, showed 100 per cent efficacy and safety in preclinical trials conducted on animals. The vaccine, designed to target cancers such as colorectal cancer, glioblastoma, and melanoma, can prevent tumour development and promote tumour regression.

 

https://www.timesnownews.com/health/russia-says-its-enteromix-cancer-vaccine-has-achieved-100-success-rate-in-trials-article-152701442

 

 

 

Exaggerated claims about Russia’s cancer vaccine Enteromix sweep across Africa

September 29, 2025

 

"In September 2025, the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed preclinical trials with promising results. Following this announcement, posts spread on social media in Africa claiming that a Russian vaccine called Enteromix, which they described as mRNA-based, was a “cure” for cancer. The posts also claimed the vaccine was ready for general use and would be available for free. However, the claims conflated several Russian vaccines still under development and oncology vaccine specialists poured cold water on the claims, saying reliable clinical evidence for Enteromix is not yet available. [emphasis added]

...

Several Russian cancer vaccines are currently in development, according to statements by Russian officials and scientists. One of these is Enteromix, which uses viruses to attack tumours. Another one uses mRNA technology. These seem to have been conflated in the claims circulating online. [emphasis added]

...

Ready for market? 

There is no evidence to show that Enteromix has been released to the public, let alone approved for general use, be it in Russia or anywhere else in the world."

 

(more)

 

October 2, 2025 - Corrects to state that Enteromix is not an mRNA vaccine and adds context about Russia developing multiple cancer vaccines.

 

Agence France-Presse

https://factcheck.afp.com/doc.afp.com.76UX8KE

 

 

57 minutes ago, TallGuyJohninBKK said:

the Russian Federal Medical and Biological Agency announced that a Russian cancer vaccine had passed preclinical trials with promising results

 

I don't believe my links stated the "vaccine" was ready for the general public.  It was a response to a post about the potential use of "mRNA" in treating "cancer."  An indicator of things to come.

 

But as we all know, "vaccines" aren't real, "mRNA" is a fantasy, and "cancer" doesn't exist.

 

It's all a grand conspiracy of "Big White Coat" to force us to eat "bugs", which are mythical creatures like "viruses", and be happy.

 

===============

Russia did not announce an mRNA cancer vaccine called Enteromix was ready for clinical use in September 2025. The claims were combining information about three different cancer vaccines in development in Russia into one. A Russian official said a vaccine for colorectal cancer was ready for clinical use. Russian scientists were also working on broad-spectrum cancer vaccines at the time, one of which was an mRNA vaccine and another one called Enteromix, that used cancer-fighting viruses. But both were still in trials and not ready for widespread use.

 

https://www.snopes.com/fact-check/russia-enteromix-mrna-cancer-vaccine/

 

But can you trust "Big Fact Check"?

 

 

 

 

A post with an inflammatory  unsourced and unsubstantiated claim has been removed.